- VernacularTitle:经膀胱路径机器人辅助腹腔镜根治性前列腺切除术13例报告
- Author:
Hang BI
1
;
Delai FU
1
;
Jianping LI
1
;
Xiaoshuang TANG
1
;
Haiwen CHEN
1
;
Qidong LUO
1
;
Qi CHEN
1
;
Ning NAN
1
;
Li WANG
1
;
Tie CHONG
1
;
Zhaolun LI
1
Author Information
- Publication Type:Journal Article
- Keywords: tranvesical approach; prostate cancer; robot-assisted laparoscopic radical prostatectomy; immediate continence rate; sexual function
- From: Journal of Modern Urology 2023;28(5):413-416
- CountryChina
- Language:Chinese
- Abstract: 【Objective】 To share the technical key points and experience of transvesical robot-assisted radical prostatectomy (TvRARP). 【Methods】 The clinical data of 13 patients with prostate cancer (PCa) receiving TvRARP during Nov.2021 and May 2022 were collected. The operation time, estimated blood loss, blood transfusion rate, catheter removal time, postoperative length of hospital stay, immediate urinary continence rate, postoperative IIEF-5 score and perioperative complications were evaluated. 【Results】 The operation time was (142±39) min, estimated intraoperative blood loss was (76±40) mL, and no transfusion was needed. The median postoperative IIEF-5 score was 16 (12-22), hospital stay 3 (2-5)days, and catheter removal time 7(5-14)days. Of all 13 patients, 12(92.3%) achieved immediate urinary continence at the removal of catheter. There were no postoperative complications of Clavien Ⅲ and above. Clavien Ⅰ-Ⅱ complications were observed in 4 patients (30.8%). 【Conclusion】 TvRARP is feasible and safe for selected patients with clinically localized PCa, which can ensure promising postoperative urinary continence and preserve erectile functional.